E Fund HK's Chief Investment Officer, Global Equity - Jeff Li Highlights "Three Foundational Shifts" at Bloomberg Invest Hong Kong 2026

2026-06-11 21:24
E Fund HK's Chief Investment Officer, Global Equity - Jeff Li Highlights "Three Foundational Shifts" at Bloomberg Invest Hong Kong 2026
E Fund HK's Chief Investment Officer, Global Equity - Jeff Li Highlights "Three Foundational Shifts" at Bloomberg Invest Hong Kong 2026

HONG KONG, June 11, 2026 /PRNewswire/ -- Following yesterday's Bloomberg Invest Hong Kong 2026 conference, Mr. Jeff Li, Chief Investment Officer (Global Equity) of E Fund (Hong Kong) delivered a keynote speech on the new era of China's capital markets.

Jeff Li: China Has Entered a New Era

In his address to global investors on June 10, Jeff Li, Chief Investment Officer, Global Equity at E Fund (Hong Kong), outlined three foundational shifts reshaping the investment landscape:

  • From consumer leadership to technology leadership – Chinese firms are now global frontier-setters in EV batteries, biotech, robotics, and AI.
  • From localization to true globalization – Today's leading Chinese enterprises are born global, with deeply integrated multinational operations spanning Europe to Southeast Asia.
  • From "growth first" to sustainable, high-quality growth – A paradigm shift toward disciplined capital allocation, profitability, and structural ROE improvements.

"These shifts are not predictions—they are already underway," Li told the Bloomberg Invest audience. "At E Fund, we are positioning our global equity strategies to capture this transformation."

Cross-Market Collaboration with HKEX

In a powerful demonstration of cross-market collaboration championed by E Fund's investment leadership, the firm has entered into a licensing agreement with Hong Kong Exchanges and Clearing Limited (HKEX) to launch the first ETF tracking the HKEX Tech 100 Index – HKEX's first self-developed Hong Kong equity index.

The index spans 100 of Hong Kong's largest technology companies across six innovation themes:

  • AI
  • Biotech & Pharmaceutical
  • EV & Smart Driving
  • IT
  • Internet
  • Robotics

Notably, all constituents are 100% Stock Connect eligible, empowering mainland investors to capture Hong Kong's vibrant tech opportunities at scale.

"E Fund combines global perspectives with deep local expertise—bridging markets to unlock long-term value," Jeff Li reiterated. As Presenting Sponsor of Bloomberg Invest Hong Kong 2026, E Fund engaged directly with global investors to navigate this transformative era.

Latest
Frost & Sullivan Celebrates 65 Years of Enabling Growth in Times of Transformation
Laminar Named a 2026 World Economic Forum Technology Pioneer
DREAM PAIRS Expands Its Iconic Chunk Heeled Sandals Collection, Bringing Best-Selling Style, Wearable Comfort, and Everyday Versatility to Every Heel Height
LEIFRAS Co., Ltd. Achieves Multi-Sport School Presence Across All 47 Prefectures in Japan on Its 25th Anniversary
Topic: Binance Commits $250,000 to Support Frontline Ebola Response in Uganda and DRC
ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens
Jensen Huang Keeps Sounding the Alarm. Lai Ching-te Keeps Missing the Point.
TECNO POVA 8 5G Launches with 2-Day Battery, Alive Matrix Display, and Practical AI
Fake Enforcement, Real Harassment: Taiwan Pushes Back Against China's Maritime Claims
China Declares Taiwan's Eastern Waters Its Own "Coastal Sea" After Five-Day Enforcement Blitz
KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"
Cynosure Lutronic's XERF™, Worldwide Adoption Accelerates, Now 3x Faster
Yakult Singapore Introduces First New Flavour in 46 Years
Compass Offices Officially Opens New Flexible Workspace at Silvercord Tower 1 in Tsim Sha Tsui
Exclusive | KMT Chair Cheng Li-wun Puzzles Washington, but D.C. Scholar Calls Her 'Refreshing'
TTM+ 2026 opens in Pattaya advancing sustainable and wellness-led tourism
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health